Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5503849 | Parkinsonism & Related Disorders | 2017 | 14 Pages |
Abstract
Although recruitment goals were not met, which precluded demonstration of any potential beneficial effect of relamorelin, unique and important insights with regard to the nature of constipation in PD were recognized, which hopefully will lead to more effective clinical trials in the future. It is clear that what PD patients understand as constipation may be more complex than previously realized and does not appear to be characterized by decreased stool frequency alone.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
The Parkinson Study Group The Parkinson Study Group,